<DOC>
	<DOC>NCT00163488</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and tolerability of combined ciclesonide nasal spray administered along with a fixed combination of inhaled fluticasone dipropionate/salmeterol.</brief_summary>
	<brief_title>Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Perennial</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<mesh_term>Fluticasone Propionate, Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Main General good health, other than perennial allergic rhinitis History and diagnosis of perennial allergic rhinitis by skin prick Normal body weight as defined by the study protocol Main Pregnancy, nursing, or plans to become pregnant or donate gametes (ova or sperm) for in vitro fertilization during the study period or for 30 days following the study period Participation in any investigational drug trial within the 30 days preceding the Screening Visit A known hypersensitivity to any corticosteroid or any of the excipients in the formulations Use of any prohibited concomitant medications as defined by the study protocol Previous participation in an intranasal ciclesonide study Nonvaccinated exposure to or active infection with, chickenpox or measles within the 21 days preceding the Screening Visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Allergy</keyword>
	<keyword>Perennial Allergic Rhinitis</keyword>
	<keyword>Allergic Rhinitis</keyword>
	<keyword>Hay Fever</keyword>
</DOC>